Suppr超能文献

125I-(苏氨酸34,异亮氨酸37)-胆囊收缩素31-39:一种用于鉴定胰腺腺泡上胆囊收缩素受体及C端胆囊收缩素肽放射免疫测定的不可氧化示踪剂

125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides.

作者信息

Fourmy D, Pradayrol L, Vaysse N, Susini C, Ribet A

出版信息

J Immunoassay. 1984;5(1-2):99-120. doi: 10.1080/01971528408063001.

Abstract

A derivative of the C-terminal nonapeptide of CCK, namely (Thr34, Nle37) - CCK31-39 was radio-iodinated by conjugation with 125I-Bolton-Hunter reagent. The labelled peptide was purified by RP-HPLC on a C-18 column. Validation of the iodinated peptide was performed by measuring its biological integrity and by studying its binding characteristics on pancreatic acini. 125I-(Thr, Nle)-CCK-9 present the same ability to stimulates amylase release than (Thr, Nle)- CCK-9 and CCK-8. Binding of the radio-ligand to CCK receptors is specific, reversible, saturable. Inhibition of the binding by CCK-related peptides correlates well their biological potencies. 125I-(Thr, Nle)-CCK-9 is able to interact with high affinity CCK receptors. Furthermore, 125I-(Thr, Nle)-CCK-9 is recognized by C-terminal CCK directed antibodies. This reliable tracer could be used as a replacement of CCK-8 since it is protected from risks of oxidation.

摘要

胆囊收缩素(CCK)C末端九肽的衍生物,即(苏氨酸34,正亮氨酸37)-CCK31 - 39,通过与125I - 博尔顿 - 亨特试剂偶联进行放射性碘化。标记的肽通过C - 18柱上的反相高效液相色谱法(RP - HPLC)纯化。通过测量其生物学完整性并研究其在胰腺腺泡上的结合特性来进行碘化肽的验证。125I -(苏氨酸,正亮氨酸)-CCK - 9刺激淀粉酶释放的能力与(苏氨酸,正亮氨酸)-CCK - 9和CCK - 8相同。放射性配体与CCK受体的结合是特异性的、可逆的、可饱和的。CCK相关肽对结合的抑制作用与其生物学活性密切相关。125I -(苏氨酸,正亮氨酸)-CCK - 9能够与高亲和力的CCK受体相互作用。此外,125I -(苏氨酸,正亮氨酸)-CCK - 9可被C末端CCK定向抗体识别。这种可靠的示踪剂可作为CCK - 8的替代品,因为它可避免氧化风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验